Feng, Xiaodong_ Xie, Hong-Guang - Applying pharmacogenomics in therapeutics-CRC Press (2016)

32 Applying Pharmacogenomics in Therapeutics
163. Kadafour, M., et al. Survey on warfarin pharmacogenetic testing among anticoagulation
providers. Pharmacogenomics, 2009; 10(11): 1853–60.
164. Marsh, S. and T. van Rooij. Challenges of incorporating pharmacogenomics into clinical
practice. Gastrointest Cancer Res, 2009; 3(5): 206–7.
165. Lee, K.C., J.D. Ma, and G.M. Kuo. Pharmacogenomics: Bridging the gap between
science and practice. J Am Pharm Assoc (2003), 2010; 50(1): e1–14; quiz e15–17.
166. French, B., et al. Statistical design of personalized medicine interventions: The
Clarification of Optimal Anticoagulation through Genetics (COAG) trial. Trials, 2010;
11: 108.
167. Eiselt, R., et al. Identification and functional characterization of eight CYP3A4 protein
variants. Pharmacogenetics, 2001; 11(5): 447–58.
168. Dodson, C. Knowledge and attitudes concerning pharmacogenomics among healthcare
professionals. Personal Med, 2011; 8(4): 421–8.
169. Hoop, J.G., et al. The current state of genetics training in psychiatric residency: Views
of 235 U.S. educators and trainees. Acad Psychiatry, 2010; 34(2): 109–14.
170. American Academy of Family Physicians. Core Educational Guidelines. Medical
Genetics: Recommended Core Educational Guidelines for Family Practice Residents.
AAFP, 1999.
171. Association of American Medical Colleges. Contemporary Issues in Medicine: Genetic
Education. AAMC, 2004, Washington DC.